JBM (Healthcare) Limited (HKG:2161)
2.780
+0.060 (2.21%)
At close: Feb 13, 2026
JBM (Healthcare) Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 194.2 | 205.85 | 140.81 | 152.27 | 69.84 | 94.38 |
Short-Term Investments | 44.36 | 28.71 | 26.41 | 11.22 | 9.4 | 6.69 |
Cash & Short-Term Investments | 238.55 | 234.56 | 167.21 | 163.48 | 79.24 | 101.07 |
Cash Growth | 25.77% | 40.27% | 2.28% | 106.31% | -21.59% | 9.83% |
Accounts Receivable | 206.64 | 134.13 | 106.11 | 110.66 | 128.14 | 133.81 |
Other Receivables | 4.61 | 1.42 | 2.63 | 2.38 | 9.48 | 1.42 |
Receivables | 211.24 | 135.55 | 108.75 | 113.04 | 137.62 | 135.23 |
Inventory | 92.2 | 82.24 | 91.59 | 54.56 | 47.87 | 48.02 |
Total Current Assets | 541.99 | 452.35 | 367.54 | 331.08 | 264.74 | 284.31 |
Property, Plant & Equipment | 169.26 | 142.21 | 146.39 | 164.33 | 179.96 | 190.07 |
Long-Term Investments | 3.61 | 3.22 | 13.88 | 33.83 | 44.98 | 46.26 |
Goodwill | - | 266.84 | 266.84 | 266.84 | 260.54 | 260.54 |
Other Intangible Assets | 1,014 | 550.31 | 571.97 | 591.07 | 568.3 | 591.21 |
Long-Term Deferred Tax Assets | 3.89 | 2.2 | 1.9 | 2.83 | 2.78 | 2.06 |
Other Long-Term Assets | 39.43 | 128 | 20.16 | 13.1 | 11.19 | 6.74 |
Total Assets | 1,772 | 1,545 | 1,389 | 1,403 | 1,332 | 1,381 |
Accounts Payable | 24.72 | 21.33 | 22.17 | 30.7 | 23.18 | 14.12 |
Accrued Expenses | 10.6 | 7.5 | 7.03 | 20.87 | 4.81 | 5.69 |
Current Portion of Long-Term Debt | 20 | 149.8 | 71.2 | 91.2 | 60 | 60 |
Current Portion of Leases | 15.54 | 13.12 | 11.31 | 11.62 | 15.89 | 12.88 |
Current Income Taxes Payable | 40.8 | 19.22 | 20.61 | 9.38 | 4.96 | 7.29 |
Current Unearned Revenue | 4.4 | 2.63 | 6.05 | 2.93 | 2.66 | 1.7 |
Other Current Liabilities | 70.37 | 67.41 | 83.2 | 27.96 | 17.11 | 35.46 |
Total Current Liabilities | 186.44 | 281.01 | 221.57 | 194.66 | 128.61 | 137.14 |
Long-Term Debt | 330 | - | 43.8 | 63.8 | 115 | 175 |
Long-Term Leases | 8.82 | 8.83 | 7.1 | 13.47 | 22.2 | 20.04 |
Long-Term Deferred Tax Liabilities | 114.84 | 91.32 | 94.28 | 100.16 | 97.48 | 102.07 |
Total Liabilities | 640.1 | 381.16 | 366.75 | 372.1 | 363.3 | 434.25 |
Common Stock | 8.17 | 8.14 | 8.31 | 9.08 | 8.94 | 8.94 |
Additional Paid-In Capital | 622.55 | 622.55 | 634.28 | 722.54 | 703.54 | 703.54 |
Retained Earnings | 469.65 | 441.15 | 359.77 | 281.16 | 228.53 | 203.91 |
Comprehensive Income & Other | -29.31 | 10.18 | -31.68 | -27.26 | -11.81 | -11.68 |
Total Common Equity | 1,071 | 1,082 | 970.68 | 985.51 | 929.2 | 904.71 |
Minority Interest | 60.72 | 81.94 | 51.27 | 45.48 | 39.99 | 42.24 |
Shareholders' Equity | 1,132 | 1,164 | 1,022 | 1,031 | 969.19 | 946.94 |
Total Liabilities & Equity | 1,772 | 1,545 | 1,389 | 1,403 | 1,332 | 1,381 |
Total Debt | 374.36 | 171.75 | 133.41 | 180.1 | 213.09 | 267.92 |
Net Cash (Debt) | -135.81 | 62.81 | 33.81 | -16.62 | -133.85 | -166.85 |
Net Cash Growth | - | 85.80% | - | - | - | - |
Net Cash Per Share | -0.15 | 0.07 | 0.04 | -0.02 | -0.15 | -0.20 |
Filing Date Shares Outstanding | 817.3 | 814 | 831.25 | 907.59 | 893.69 | 893.69 |
Total Common Shares Outstanding | 817.3 | 814 | 831.25 | 907.59 | 893.69 | 893.69 |
Working Capital | 355.56 | 171.34 | 145.97 | 136.42 | 136.13 | 147.17 |
Book Value Per Share | 1.31 | 1.33 | 1.17 | 1.09 | 1.04 | 1.01 |
Tangible Book Value | 57.36 | 264.87 | 131.86 | 127.59 | 100.37 | 52.96 |
Tangible Book Value Per Share | 0.07 | 0.33 | 0.16 | 0.14 | 0.11 | 0.06 |
Land | - | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 |
Buildings | - | 160.44 | 152 | 150.44 | 153.4 | 147.87 |
Machinery | - | 121.37 | 120.02 | 122.28 | 118.01 | 118.21 |
Leasehold Improvements | - | 10.16 | 9.18 | 10.09 | 9.33 | 7.5 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.